SCHEMBL14065441

SCHEMBL14065441

CO[C@@H]1c2ccccc2CC[C@H]1OC

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.46
PDPK1 O15530 1/20 0.46
PIN1 Q13526 1/20 0.41
SRD5A1 P18405 2/20 0.41
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
CYP2D6 P10635 2/20 0.40
SLC6A3 Q01959 1/20 0.40
CYP11B2 P19099 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854364 1.00 IDO1 (0.46) IDO1PDPK1PIN1SRD5A1SLC6A2
SCHEMBL16866691 0.82 HTR2A (0.47) IDO1PDPK1CYP2D6
SCHEMBL10283375 0.81 DRD2 (0.47) IDO1PDPK1PIN1SRD5A1CYP11B2
SCHEMBL12452014 0.81 DRD2 (0.47) IDO1PDPK1PIN1SRD5A1CYP11B2
SCHEMBL13998258 0.80 IDO1 (0.44) IDO1PDPK1PIN1SRD5A1CYP11B2
SCHEMBL15375784 0.80 IDO1 (0.49) IDO1PDPK1PIN1SLC6A2SLC6A4
SCHEMBL783972 0.80 IDO1 (0.49) IDO1PDPK1PIN1SRD5A1SIGMAR1
SCHEMBL17145170 0.77 PRCP (0.44) IDO1PDPK1PIN1SRD5A1CYP2D6
SCHEMBL802812 0.77 PRCP (0.44) IDO1PDPK1PIN1SRD5A1CYP2D6
SCHEMBL12452306 0.77 PRCP (0.44) IDO1PDPK1PIN1SRD5A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7420003-B2 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids ASTRAZENECA AB (SE) 2008-09-02 US disclosed
US-7420003-B2 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids ASTRAZENECA AB (SE) 2008-09-02 US disclosed